FR

Make a donation

Friday, August 11 2017

Myeloma Matters : August 2017

  • Better Late than Never! We're Pleased to Announce the Launch of the very first Vancouver Multiple Myeloma March
  • Register Now For One of the 16 Multiple Myeloma Marches, Across 7 Provinces
  • Daratumumab (Darzalex®) Receives an Initial Positive Recommendation for Reimbursement from the pan-Canadian Oncology Drug Review (pCODR)
  • A Second Phase III Study Shows That Carfilzomib (Kyprolis®) Significantly Improves Overall Survival in Patients with Relapsed Multiple Myeloma
  • The Myeloma Canada Research Network (MCRN) is Trailblazing the Clinical Research Landscape with MCRN 003 – The KCd Trial
  • An Increasing Body of Research Links Obesity to Myeloma Progression
  • Spotlight on Lorelei Dalrymple: Myeloma Patient and Chair of the Myeloma Canada Patient Advisory Council
  • Become a Myeloma Advocate
  • Do All of Your Back-to-School Shopping Online and Support Myeloma Canada While You’re at it. It won’t Cost a Penny More!
  • In the Community

Read more...